SCOPUS 정보 검색 플랫폼

Journal of Clinical Pharmacology

Volumn 40, Issue 6, 2000, Pages 606-615

Extravascular administration of interferon alfa-n3 increases serum exposure and 2-5(A) synthetase activity

(8) Sturgill, M G a,b Rashidbaigi, A c Liao, M J c Zhao, X X c Hua, Ji c Trout, R d Knill, J R c Grasing, K W e

a RUTGERS UNIVERSITY (United States)

b ROBERT WOOD JOHNSON MEDICAL SCHOOL (United States)

c Interferon Sciences Inc (United States)

d Department of Statistics and Computer Science (United States)

e VETERANS AFFAIRS MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHAN3 INTERFERON; CONSENSUS INTERFERON; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ALPHAN3 INTERFERON; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOMODULATION; MALE; NORMAL HUMAN; PHASE 3 CLINICAL TRIAL;

EID: 0033663696 PISSN: 00912700 EISSN: None Source Type: Journal
DOI: 10.1002/j.1552-4604.2000.tb05986.x Document Type: Article

Times cited : (3)

References (21)

1
- 12644274686
- Treatment of chronic hepatitis C with interferon alfa-n3: A multicenter, randomized, open-label trial
- (1997) Hepatology , vol.25 , pp. 445-448
- Simon, D.M.¹ Gordon, S.C.² Kaplan, M.M.³ Koff, R.S.⁴ Regenstein, F.⁵ Everson, G.⁶

2
- 0027399427
- Nomenclature of the human interferon genes
- (1993) J Interferon Res , vol.13 , pp. 61-62
- Diaz, M.O.¹ Bohlander, S.² Allen, G.³

3
- 0026636546
- Absence of neutralizing antibodies to interferon in condyloma acuminata and cancer patients treated with natural human leukocyte interferon
- (1992) J Infect Dis , vol.165 , pp. 757-760
- Liao, M.J.¹ Axelrod, H.R.² Kuchler, M.³ Yip, Y.K.⁴ Kirkbright, E.⁵ Testa, D.⁶

4
- 0030823332
- Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3
- (1997) Human Antibodies , vol.8 , pp. 129-136
- Zhao, X.X.¹ Hua, J.² Smith, T.³ Ferencz-Biro, K.⁴ Liao, M.J.⁵ Rashidbaigi, A.⁶

5
- 0025190653
- The potential of interferons in malignant disease
- (1990) Drugs , vol.39 , pp. 1-6
- Okita, K.¹ Kaneko, T.²

6
- 0029944112
- Phase I trial of interferon alfa-n3 in early-stage HIV-1 disease: Evidence for drug safety, tolerance, and antiviral activity
- (1996) J Infect Dis , vol.173 , pp. 1107-1114
- Skillman, D.¹ Malone, J.² Decker, C.³ Wagner, K.⁴ Mapou, R.⁵ Liao, M.J.⁶

7
- 0022446413
- Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: Effects of dose, schedule, and route of administration
- (1986) J Interferon Res , vol.6 , pp. 189-198
- Merritt, J.A.¹ Ball, A.² Sielaff, K.M.³ Meltzer, D.M.⁴ Borden, E.C.⁵

8
- 0019755391
- A convenient and rapid cytopathic effect inhibition assay for interferon
- (1981) Methods Enzymol , vol.78 , pp. 387-394
- Familletti, P.C.¹ Rubinstein, S.² Peska, S.³

9
- 0021840631
- Measurement of 2'-5'-oligoadenylate synthetase in patients receiving interferon-alpha
- (1985) J Interferon Res , vol.5 , pp. 191-198
- Merritt, J.A.¹ Borden, E.C.² Ball, L.A.³

10
- 0004259632
- Apex, NC: Scientific Consulting
- (1992) PCNONLIN, version 4.2. 4th ed.
- Metzler, C.M.¹ Weiner, D.L.²

11
- 0023442604
- Fitting curves to data using nonlinear regression: A practical and nonmathematical review
- (1987) FASEB J , vol.1 , pp. 365-374
- Motulsky, H.J.¹ Ransnas, L.A.²

12
- 0003414189
- Mountain View, CA: Mayfield
- (1992) Basic Statistics for the Health Sciences. 2nd ed.
- Kuzma, J.W.¹

13
- 0017331381
- Interpretation of plasma concentration-time curves after oral dosing
- (1977) J Pharm Sci , vol.66 , pp. 178-180
- Ronfeld, R.A.¹ Benet, L.Z.²

14
- 0030980940
- Pharmacokinetic studies with recombinant cytokines: Scientific and practical considerations
- (1997) Clin Pharmacokinet , vol.32 , pp. 368-381
- Piscitelli, S.C.¹ Reiss, W.G.² Figg, W.D.³ Petros, W.P.⁴

15
- 0024786949
- Side effects of alpha interferon
- (1989) Semin Liver Dis , vol.9 , pp. 273-277
- Renault, P.E.¹ Hoofnagle, J.H.²

16
- 0023546517
- Pharmacokinetics of interferon α-2b in healthy volunteers
- (1987) J Clin Pharmacol , vol.27 , pp. 432-435
- Radwanski, E.¹ Perentesis, G.² Jacobs, S.³ Oden, E.⁴ Affrime, M.⁵ Symchowicz, S.⁶

17
- 0021684554
- 2 interferon in patients with malignancies
- (1984) Am J Hematol , vol.17 , pp. 363-371
- Shah, I.¹ Band, J.² Samson, M.³ Young, J.⁴ Robinson, R.⁵ Bailey, B.⁶

18
- 0023933171
- Interferon-αn1 in children with recurrent acute lymphocytic leukemia: A phase I study of pharmacokinetics and tolerance
- (1988) J Interferon Res , vol.8 , pp. 309-318
- Wells, R.J.¹ Weck, P.K.² Baehner, R.L.³ Krivit, W.⁴ Raney, R.B.⁵ Ortega, J.A.⁶

19
- 0004061014
- New York: Marcel Dekker
- (1982) Pharmacokinetics. 2nd ed.
- Gibaldi, M.¹ Perrier, D.²

20
- 0020408324
- The kidney is the main site of interferon catabolism
- (1982) J Interferon Res , vol.2 , pp. 309-314
- Bocci, V.¹ Pacini, A.² Muscettola, M.³ Pessina, G.P.⁴ Paulesu, L.⁵ Bandinelli, L.⁶

21
- 0021932547
- Lack of in vivo activation of the interferon system in Hb(s)Ag positive chronic active hepatitis
- (1985) Hepatology , vol.5 , pp. 171-174
- Poitrine, A.¹ Chousterman, S.² Chousterman, M.³ Naveau, S.⁴ Thang, M.N.⁵ Chaput, J.-C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.